Tag: <span>carcinogen risk</span>

Home / carcinogen risk
Post

FDA supports limited distribution of antismoking drug Chantix despite carcinogen risk

July 16, 2021, 05:13 PM Josh Sullivan Associate Editor Earlier this month, the FDA alerted the public that Pfizer had voluntarily recalled its stop-smoking drug Chantix after finding elevated levels of cancer-causing nitrosamines. Now, the FDA is permitting certain manufacturers to temporarily distribute the drug that has more than the usual nitrosamine, so long as...